The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients ...

Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years — — Conference call today at 4:30 p.m. ET — BRISBANE, Calif., Feb. 26, 2026 ...

Florida-based trainer Hernan Parra has been suspended 15 days and fined $2,500 for two dexamethasone positive test results in two horses.

Respiratory physicians Dr Hannah Petty and Dr Nita Sehgal discuss management of treatment resistant asthma in primary care ...

Severe neurodegeneration is one of several clinical features of ataxia-telangiectasia (AT), yet control of CNS symptoms in patients with AT has received little attention. Buoni et al. have presented a ...

US FDA approves Sanofi and Regeneron’s Dupixent for allergic fungal rhinosinusitis: Paris Thursday, February 26, 2026, 15:00 Hrs [IST] The US Food and Drug Administration (FDA) ...

Learn more about whether Celldex Therapeutics, Inc. or Catalyst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Budget impact analysis finds omalizumab biosimilars in Europe could cut payer costs by €641M in 5 years, expanding access and ...